Detail akcie IDEXX Labs online

Business Summary: IDEXX Laboratories, Inc. develops, manufactures, and distributes products and provides services primarily for the companion animal veterinary; livestock, poultry and dairy; and water testing industries. It also manufactures and sells human medical point-of-care diagnostic products. Its products and services include point-of-care veterinary diagnostic products, comprised of instruments, consumables, and rapid assay test kits. It also includes veterinary reference laboratory diagnostic and consulting services. It offers practice management systems, software and diagnostic imaging systems and services used by veterinarians. It also offers health monitoring, biological materials testing, laboratory diagnostic instruments, and services used by the biomedical research community. The Company provides diagnostic and health-monitoring products for livestock, poultry, and dairy; and products that test water for certain microbiological contaminants.
Financial Summary: BRIEF: For the three months ended 31 March 2026, IDEXX Laboratories Inc revenues increased 14% to $1.14B. Net income increased 15% to $278.4M. Revenues reflect CAG segment increase of 14% to $1.97B, Water segment increase of 11% to $50.3M, LPD segment increase of 14% to $32.5M, United States segment increase of 11% to $725.2M, Europe & Middle East & Africa (EMEA) (Region) segment increase of 26% to $257.1M.